Rachel Burga, PhD

Immunologist and Bioengineer passionate about Cancer Immunotherapy. Assistant Editor @cytotherapy. Food and Fitness enthusiast. All views are my own.

[Alicia Didsbury @AliciaD_nz]

Behind the scenes ISCT TV day 3: our anchorman @Dr_ConneCTed, the wonderful @Lizettecaba and @ISCT_ESP Chair, @cytotherapy assistant editor and all-round superstar @RachelBurga
#ISCT2024 @ISCTglobal

[Rachel Burga, PhD @RachelBurga]

Thank you Tom and Emily @EWhiteheadFdn for sharing your journey and for your passionate advocacy efforts. For us #celltherapy and #genetherapy scientists, YOU are our why. #ISCT2024 @ISCTglobal @cytotherapy

[Cytotherapy @cytotherapy]

Grateful for the amazing contributions of the #Cytotherapy Editorial Team, Associate Editors, Editorial Board, and @ElsevierConnect for a productive strategic working lunch @ISCTglobal

[Rachel Burga, PhD @RachelBurga]

First plenary of the meeting - congratulations to @ISCTglobal on 30 years!!! #ISCT2024

[Rachel Burga, PhD @RachelBurga]

#ISCT2024 is here! Whether it's your 1st or your 40th Annual Meeting, we invite you to join us in championing our @ISCT_ESP. They've played a crucial role in planning and participating in this year's event, learning from our leaders🌟 #CGT #Networking #NextGeneration @ISCTglobal

[Cytotherapy @cytotherapy]

Meet our Assistant Editor and the voice of our social media and newsletters @RachelBurga #MeetTheTeamMonday

[ISCT @ISCTglobal]

2 weeks until ISCT 2024 Vancouver!

Don't miss these must-attend sessions at ISCT 2024 highlighted by ISCT Assistant Editor Rachel Burga.

Register now: https://t.co/KPJuaql7Ut

[Rachel Burga, PhD @RachelBurga]

Have you heard? We’ve got a new look!

[ISCT @ISCTglobal]

Exciting news! Cytotherapy, the official journal of ISCT, has a new look! Check out the redesigned cover in the upcoming May issue.

[Rachel Burga, PhD @RachelBurga]

Look at this amazing regional growth! Excited to officially kick off the 2023-2024 @ISCT_ESP Mentoring Program with this great team led by Elana and Nisha!

[Rachel Burga, PhD @RachelBurga]

Fellow ESPs, it’s your time to shine! #ISCTNA2023 @ISCT_ESP @ISCTglobal

[Cytotherapy @cytotherapy]

📣 cell-and-gene-therapy-enthusiasts, we are thiiis close to hitting 500 followers! Thanks to all who follow along for content from @ISCTglobal ‘s official Journal. Give us a share and help us break 500!

[ISCT @ISCTglobal]

The ISCT ESP Committee is seeking dedicated and enthusiastic new members.

Take part in monthly meetings with members from across the globe to develop and execute projects in mentoring, training and community engagement.

Learn more and apply:
https://t.co/oUto5faCJH

[BWFUND @BWFUND]

Graduate Diversity Enrichment Program awards provide $5K for 2 years to underrepresented minority PhD students in NC for opportunities for greater science & research enrichment experiences
#bwfgdep #bwfrtp

Details:
https://t.co/R8zuoNRhMx

Deadline in 5 days!

[Rachel Burga, PhD @RachelBurga]

Awesome work from some hardworking @ISCT_ESP members!

[Cytotherapy @cytotherapy]

Can't wait for the #ISCT2023 content to be published? Refresh yourself with the @ISCT_ESP insights from the #ISCT2022 Annual Meeting here: https://t.co/hkrbDKcyiL

[ISCT @ISCTglobal]

Wishing everyone a Happy Holidays from the ISCT Early Stage Professional Committee🎄

ISCT is looking forward to another exciting year supporting the development of ESPs in 2023!

[Rachel Burga, PhD @RachelBurga]

@FarnersRiera @WashU_OBGYN Ah Farners this is so exciting! Huge congratulations to you and I can’t wait to see the exciting work coming out of your lab!

[Rachel Burga, PhD @RachelBurga]

Gotta love that unique TLS signature when you see it!

[Cytotherapy @cytotherapy]

Catch Comish Editor @DrPHanley and Asst Editor @RachelBurga today as they present their hallmark Manuscript Writing Workshop at #ABTCelgen, sponsored by @cytotherapy and @ISCTglobal

[Cytotherapy @cytotherapy]

Ending #TuesdayswithGiants with a bang we've got a conversation with visionaries @BLLPHD and @carlhjune on their successful work advancing #CART to the clinic, setting the scene for the hope of transformative, personalized, #immunotherapy @EWhiteheadFdn https://t.co/hl72jgujFI

[Rachel Burga, PhD @RachelBurga]

So proud and excited - first and foremost for patients and families who will benefit, and secondly for the hard work that our team has committed to develop this therapeutic; now an FDA cleared engineered TIL product ready for the clinic ! #TILtherapy #immunotherapy #ObsidianRocks

[Obsidian Therapeutics @Obsidian_Tx]

#INDClearance - Today we announced the @FDA clearance of the #IND application for an @MDAndersonNews-sponsored Phase 1 clinical study of OBX-115, Obsidian’s lead engineered tumor-infiltrating lymphocyte (TIL) therapy candidate.

Read more: https://t.co/aCLjbroYUN